Journal of Radiotherapy

Clinical Study

Intensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes

Table 1

Clinical characteristics of 60 patients with hypopharyngeal-laryngeal cancer.
Characteristics (%)
Site 
 Hypopharynx34 (56.7)
 Larynx26 (43.3)
Age (years) 
 Median (range)63 (40–85)
Gender 
 Male52 (86.7)
 Female8 (13.3)
Histological grading 
 G231 (51.7)
 G329 (48.3)
T stage 
 T28 (13.3)
 7T341 (68.3)
 T411 (18.3)
N stage 
 N020 (33.3)
 N113 (21.7)
 N225 (41.7)
 N32 (3.3)
Tumor stage 
 III29 (48.3)
 IV31 (51.7)
Type of treatment 
 NCT-IMRT145 (75.0)
 IMRT-CCT215 (25.0)
NCT-IMRT: induction chemotherapy followed by IMRT. 2IMRT-CCT: IMRT with concurrent administration of cisplatin.